The ratings of 12 Health Care Equipment & Supplies stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
Medtronic plc (MDT) slips from a C to a D this week. Medtronic plc develops therapeutic and diagnostic medical products. For more information, get Portfolio Grader’s complete analysis of MDT stock.
Abaxis, Inc. (ABAX) gets weaker ratings this week as last week’s C drops to a D. Abaxis, Inc. is engaged in the development, manufacture, marketing and sale of portable blood analysis systems for use in the human or veterinary patient-care setting. The company also gets F’s in earnings revisions and earnings surprise. For more information, get Portfolio Grader’s complete analysis of ABAX stock.
Slipping from a C to a D rating, CONMED Corporation (CNMD) takes a hit this week. CONMED Corporation provides orthopedic products, specializing in arthroscopy and powered surgical instruments. The company also gets F’s in operating margin growth. For more information, get Portfolio Grader’s complete analysis of CNMD stock.
This week, Insulet Corporation’s (PODD) rating worsens to a D from the company’s C rating a week ago. Insulet Corporation is a medical device company that develops, manufactures and markets an insulin infusion system for people with insulin-dependent diabetes. The company also gets F’s in earnings revisions and return on equity. For more information, get Portfolio Grader’s complete analysis of PODD stock.
This is a rough week for Wright Medical Group NV (WMGI). The company’s rating falls to D from the previous week’s C. Wright Medical Group NV is a global orthopedic medical device company specializing in the design, manufacture and marketing of devices and biologic products for extremity, hip, and knee repair and reconstruction. The company also gets F’s in earnings momentum and return on equity. For more information, get Portfolio Grader’s complete analysis of WMGI stock.
Quidel Corporation (QDEL) declines this week from a C to a D. Quidel Corporation discovers, develops, manufactures, and markets rapid diagnostic products for point-of-care detection of human medical conditions and illnesses. The company also gets F’s in operating margin growth. For more information, get Portfolio Grader’s complete analysis of QDEL stock.
K2M Group Holdings, Inc.’s (KTWO) rating weakens this week, dropping to a D versus last week’s C. The company also gets F’s in earnings surprise and return on equity. For more information, get Portfolio Grader’s complete analysis of KTWO stock.
AtriCure, Inc. (ATRC) is having a tough week. The company’s rating falls from a C to a D. AtriCure, Inc. engages in developing, manufacturing, and selling cardiac surgical ablation systems designed to create precise lesions or scars in cardiac tissue in the United States and internationally. The company also gets F’s in return on equity. For more information, get Portfolio Grader’s complete analysis of ATRC stock.
Cerus Corporation (CERS) experiences a ratings drop this week, going from last week’s C to a D. Cerus Corporation is a biomedical products company engaged in the development and commercialization of the INTERCEPT Blood System. The company also gets F’s in earnings revisions, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of CERS stock.
Derma Sciences, Inc. (DSCI) earns a D this week, moving down from last week’s grade of C. Derma Sciences, Inc. markets and sells a range of skin care, wound management, and specialty securement devices. The company also gets F’s in earnings revisions. For more information, get Portfolio Grader’s complete analysis of DSCI stock.
This week, Avinger, Inc. (AVGR) drops from a D to a F rating. The company also gets F’s in earnings surprise, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of AVGR stock.
This week, Retractable Technologies, Inc.’s (RVP) rating worsens to a F from the company’s D rating a week ago. Retractable Technologies, Inc. designs, develops, manufactures and markets safety syringes and other safety medical products for the healthcare profession. The company also gets F’s in operating margin growth. For more information, get Portfolio Grader’s complete analysis of RVP stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
